Top

Published in:

26-09-2022 | Esophageal Cancer | Review Article

Esophageal Cancer: Whether and What Before or After Surgery?

Authors: Murugappan Nachiappan, V. K. Kapoor

Published in: Indian Journal of Surgical Oncology | Issue 4/2022

Abstract

Esophageal cancer is the eighth most common cancer and the sixth most common cause of cancer-related mortality worldwide. Surgery has been the mainstay of the treatment of esophageal cancer. However, given the dismal survival with surgery alone, other modalities, e.g., chemotherapy (CT) and radiotherapy (RT), have been used for the management of these cancers. This review aims to look at the evolution of multi-modality management of esophageal cancer and tries to answer certain questions pertaining to the management of these cancers.

Sun X-D, Yu J-M, Fan X-L, Ren R-M, Li M-H, Zhang G-L (2006) Randomized clinical study of surgery versus radiotherapy alone in the treatment of resectable esophageal cancer in the chest. Zhonghua Zhong Liu Za Zhi 28:784–787

Rice TW, Rusch VW, Apperson-Hansen C et al (2009) Worldwide esophageal cancer collaboration. Dis Esophagus 22:1–8. https://doi.org/10.1111/j.1442-2050.2008.00901.xCrossRef

Cooper JS, Guo MD, Herskovic A et al (1999) Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85–01). Radiat Therapy Oncol Group JAMA 281:1623–1627. https://doi.org/10.1001/jama.281.17.1623CrossRef

Minsky BD, Pajak TF, Ginsberg RJ, Pisansky TM, Martenson J, Komaki R, Okawara G, Rosenthal SA, Kelsen DP (2002) INT 0123 (Radiation Therapy Oncology Group 94–05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy. J Clin Oncol 20:1167–1174. https://doi.org/10.1200/JCO.2002.20.5.1167CrossRef

Fok M, Sham JS, Choy D, Cheng SW, Wong J (1993) Postoperative radiotherapy for carcinoma of the esophagus: a prospective, randomized controlled study. Surgery 113:138–147

Xiao ZF, Yang ZY, Liang J, Miao YJ, Wang M, Yin WB, Gu XZ, Zhang DC, Zhang RG, Wang LJ (2003) Value of radiotherapy after radical surgery for esophageal carcinoma: a report of 495 patients. Ann Thorac Surg 75:331–336. https://doi.org/10.1016/s0003-4975(02)04401-6CrossRef

Schreiber D, Rineer J, Vongtama D, Wortham A, Han P, Schwartz D, Choi K, Rotman M (2010) Impact of postoperative radiation after esophagectomy for esophageal cancer. J Thorac Oncol 5:244–250. https://doi.org/10.1097/JTO.0b013e3181c5e34fCrossRef

Ni W, Yu S, Xiao Z et al (2021) Postoperative adjuvant therapy versus surgery alone for stage IIB-III esophageal squamous cell carcinoma: a phase III randomized controlled trial. Oncologist 26:e2151–e2160. https://doi.org/10.1002/onco.13914CrossRef

Ando N, Iizuka T, Ide H et al (2003) Surgery plus chemotherapy compared with surgery alone for localized squamous cell carcinoma of the thoracic esophagus: a Japan Clinical Oncology Group Study–JCOG9204. J Clin Oncol 21:4592–4596. https://doi.org/10.1200/JCO.2003.12.095CrossRef

10.

Armanios M, Xu R, Forastiere AA, Haller DG, Kugler JW, Benson AB, Eastern Cooperative Oncology Group (2004) Adjuvant chemotherapy for resected adenocarcinoma of the esophagus, gastro-esophageal junction, and cardia: phase II trial (E8296) of the Eastern Cooperative Oncology Group. J Clin Oncol 22:4495–4499. https://doi.org/10.1200/JCO.2004.06.533CrossRef

11.

Bédard EL, Inculet RI, Malthaner RA, Brecevic E, Vincent M, Dar R (2001) The role of surgery and postoperative chemoradiation therapy in patients with lymph node positive esophageal carcinoma. Cancer 91:2423–2430CrossRef

12.

Adelstein DJ, Rice TW, Rybicki LA, Saxton JP, Videtic GMM, Murthy SC, Mason DP, Rodriguez CP, Ives DI (2009) Mature results from a phase II trial of postoperative concurrent chemoradiotherapy for poor prognosis cancer of the esophagus and gastroesophageal junction. J Thorac Oncol 4:1264–1269. https://doi.org/10.1097/JTO.0b013e3181b26f8eCrossRef

13.

Sato M, Ando N (2011) Neoadjuvant chemotherapy followed by surgery as standard treatment for stage II + III thoracic esophageal squamous cell carcinoma in Japan. Nihon Geka Gakkai Zasshi 112:104–110

14.

Medical Research Council Oesophageal Cancer Working Group (2002) Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial. Lancet 359:1727–1733. https://doi.org/10.1016/S0140-6736(02)08651-8CrossRef

15.

Allum WH, Stenning SP, Bancewicz J, Clark PI, Langley RE (2009) Long-term results of a randomized trial of surgery with or without preoperative chemotherapy in esophageal cancer. J Clin Oncol 27:5062–5067. https://doi.org/10.1200/JCO.2009.22.2083CrossRef

16.

Kelsen DP, Winter KA, Gunderson LL et al (2007) Long-term results of RTOG trial 8911 (USA Intergroup 113): a random assignment trial comparison of chemotherapy followed by surgery compared with surgery alone for esophageal cancer. J Clin Oncol 25:3719–3725. https://doi.org/10.1200/JCO.2006.10.4760CrossRef

17.

Cunningham D, Allum WH, Stenning SP et al (2006) Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 355:11–20. https://doi.org/10.1056/NEJMoa055531CrossRef

18.

Ychou M, Boige V, Pignon J-P et al (2011) Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial. J Clin Oncol 29:1715–1721. https://doi.org/10.1200/JCO.2010.33.0597CrossRef

19.

Gignoux M, Roussel A, Paillot B, Gillet M, Schlag P, Dalesio O, Buyse M, Duez N (1988) The value of preoperative radiotherapy in esophageal cancer: results of a study by the EORTC. Recent Results Cancer Res 110:1–13. https://doi.org/10.1007/978-3-642-83293-2_1CrossRef

20.

Wang M, Gu XZ, Yin WB, Huang GJ, Wang LJ, Zhang DW (1989) Randomized clinical trial on the combination of preoperative irradiation and surgery in the treatment of esophageal carcinoma: report on 206 patients. Int J Radiat Oncol Biol Phys 16:325–327. https://doi.org/10.1016/0360-3016(89)90323-4CrossRef

21.

Arnott SJ, Duncan W, Kerr GR, Walbaum PR, Cameron E, Jack WJ, Mackillop WJ (1992) Low dose preoperative radiotherapy for carcinoma of the oesophagus: results of a randomized clinical trial. Radiother Oncol 24:108–113. https://doi.org/10.1016/0167-8140(92)90287-5CrossRef

22.

Bosset JF, Gignoux M, Triboulet JP et al (1997) Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus. N Engl J Med 337:161–167. https://doi.org/10.1056/NEJM199707173370304CrossRef

23.

Tepper J, Krasna MJ, Niedzwiecki D, Hollis D, Reed CE, Goldberg R, Kiel K, Willett C, Sugarbaker D, Mayer R (2008) Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781. J Clin Oncol 26:1086–1092. https://doi.org/10.1200/JCO.2007.12.9593CrossRef

24.

van Hagen P, Hulshof MCCM, van Lanschot JJB et al (2012) Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med 366:2074–2084. https://doi.org/10.1056/NEJMoa1112088CrossRef

25.

Shapiro J, van Lanschot JJB, Hulshof MCCM et al (2015) Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial. Lancet Oncol 16:1090–1098. https://doi.org/10.1016/S1470-2045(15)00040-6CrossRef

26.

Yang H, Liu H, Chen Y et al (2018) neoadjuvant chemoradiotherapy followed by surgery versus surgery alone for locally advanced squamous cell carcinoma of the esophagus (NEOCRTEC5010): a phase III multicenter, randomized, open-label clinical trial. J Clin Oncol 36:2796–2803. https://doi.org/10.1200/JCO.2018.79.1483CrossRef

27.

Stahl M, Walz MK, Stuschke M et al (2009) Phase III comparison of preoperative chemotherapy compared with chemoradiotherapy in patients with locally advanced adenocarcinoma of the esophagogastric junction. J Clin Oncol 27:851–856. https://doi.org/10.1200/JCO.2008.17.0506CrossRef

28.

Burmeister BH, Thomas JM, Burmeister EA, Walpole ET, Harvey JA, Thomson DB, Barbour AP, Gotley DC, Smithers BM (2011) Is concurrent radiation therapy required in patients receiving preoperative chemotherapy for adenocarcinoma of the oesophagus? A randomised phase II trial. Eur J Cancer 47:354–360. https://doi.org/10.1016/j.ejca.2010.09.009CrossRef

29.

Klevebro F, Alexandersson von Döbeln G, Wang N et al (2016) A randomized clinical trial of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for cancer of the oesophagus or gastro-oesophageal junction. Ann Oncol 27:660–667. https://doi.org/10.1093/annonc/mdw010CrossRef

30.

Reynolds J, Preston S, O’Neill B et al (2017) ICORG 10–14: neoadjuvant trial in adenocarcinoma of the oesophagus and oesophagogastric junction international study (Neo-AEGIS). BMC Cancer 17:401. https://doi.org/10.1186/s12885-017-3386-2CrossRef

31.

Hoeppner J, Lordick F, Brunner T et al (2016) ESOPEC: prospective randomized controlled multicenter phase III trial comparing perioperative chemotherapy (FLOT protocol) to neoadjuvant chemoradiation (CROSS protocol) in patients with adenocarcinoma of the esophagus (NCT02509286). BMC Cancer 16:503. https://doi.org/10.1186/s12885-016-2564-yCrossRef

32.

Stahl M, Stuschke M, Lehmann N et al (2005) Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. J Clin Oncol 23:2310–2317. https://doi.org/10.1200/JCO.2005.00.034CrossRef

33.

Bedenne L, Michel P, Bouché O et al (2007) Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102. J Clin Oncol 25:1160–1168. https://doi.org/10.1200/JCO.2005.04.7118CrossRef

34.

Markar S, Gronnier C, Duhamel A, Pasquer A, Théreaux J, du Rieu MC, Lefevre JH, Turner K, Luc G, Mariette C (2015) Salvage surgery after chemoradiotherapy in the management of esophageal cancer: is it a viable therapeutic option? J Clin Oncol 33:3866–3873. https://doi.org/10.1200/JCO.2014.59.9092CrossRef

Title: Esophageal Cancer: Whether and What Before or After Surgery?
Authors: Murugappan Nachiappan
V. K. Kapoor
Publication date: 26-09-2022
Publisher: Springer India
Keywords: Esophageal Cancer
Esophagus Resection
Esophageal Cancer
Radiotherapy
Esophagus Resection
Cytostatic Therapy
Published in: Indian Journal of Surgical Oncology / Issue 4/2022
Print ISSN: 0975-7651
Electronic ISSN: 0976-6952
DOI: https://doi.org/10.1007/s13193-022-01655-y

At a glance: The STEP trials

Springer Medicine

Esophageal Cancer: Whether and What Before or After Surgery?

Abstract

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 4/2022

Mitigating Cancer Overdiagnosis

Is Young Age an Independent Prognostic Factor in Carcinoma Breast? A Single-Institution Retrospective Comparative Study from South India

Isolated Limb Perfusion of Upper Limb: How I Do It

Solid Pseudopapillary Neoplasm — Case Series and Review of Literature

Whole Breast Reconstruction in Developing India: a Cancer Surgeon’s Experience with the Pedicled Transverse Rectus Abdominis (TRAM) Flap

Predictive Factors for Unnecessary Axillary Dissection According to SLN Metastasis in T1, T2 Stage Breast Cancer